僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Encelimab is an anti-LAG3 antibody. Encelimab blocks the interaction between LAG-3 and MHC II, and enhances T-cell activation. Encelimab alone or in combination with an anti-PD-1 antibody reduces tumor size in a lymphoma mice model （A20 cell xenograft）